secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001779128-25-000039
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade Q1 revenue $54.3M (+5.4% YoY); net loss improves to $(3.5)M; reaffirms FY2025 positive Adj. EBITDA
--------------------------------------------------------------------------------

- Revenue $54.3M (+5.4% YoY); excluding exited Canada, up 10.9%.
- Net loss $(3.5)M, improved $0.7M YoY; Adj. EBITDA $(1.2)M, improved $2.3M YoY.
- Passenger segment Adj. EBITDA $0.1M, first profitable Q1 since IPO (+$2.7M YoY).
- Medical segment Adj. EBITDA $4.1M; new monthly trip volume record set in April 2025.
- Reaffirms guidance: double-digit millions of Adjusted EBITDA for full-year 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912825000039/0001779128-25-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912825000039/blde-20250512.htm
  HTML page:      https://secwatch.observer/filing/0001779128-25-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer